graphic source: encongnitive.com
The key factor is: be a drug company.
In this case, Celgene. Their drugs are Thalomid and Revlimid.
(...)
A long-running suit against Celgene, launched by Beverly Brown, who used to be the company�s sales manager, contends that:
Celgene trained its sales team to promote off-label uses to doctors; Celgene sales people intentionally lied about studies, claiming the studies showed the off-label uses were beneficial to patients; And the company omitted vital warnings about the drugs� uses from the drugs� labels.
Read more ...
0 comments:
Post a Comment